Presented by José M. Sánchez-Vizcaíno at the African Swine Fever Diagnostics, Surveillance, Epidemiology and Control Workshop, Nairobi, Kenya, 20-21 July 2011
In the ppt. Babesia is explained along-with its species, its life cycle, treatment and prevention. It explains Babesia and answers questions like, What is Babesiosis? What are the species of Babesia? What is the host of Babesia? How they are spread across the globe? What are their mode of reproduction? What is their life cycle? What is the historical background of Babesiosis? How scientist named the disease? What is the morphology of Babesia? What are the stages of Life cycle of Babesia? How Babesiosis is treated? How can we prevent Babesiosis?
Presented by José M. Sánchez-Vizcaíno at the African Swine Fever Diagnostics, Surveillance, Epidemiology and Control Workshop, Nairobi, Kenya, 20-21 July 2011
In the ppt. Babesia is explained along-with its species, its life cycle, treatment and prevention. It explains Babesia and answers questions like, What is Babesiosis? What are the species of Babesia? What is the host of Babesia? How they are spread across the globe? What are their mode of reproduction? What is their life cycle? What is the historical background of Babesiosis? How scientist named the disease? What is the morphology of Babesia? What are the stages of Life cycle of Babesia? How Babesiosis is treated? How can we prevent Babesiosis?
Participants of the workshop learn the necessary background information and techniques to diagnose Sars-CoV-2 using the mobile diagnostic laboratory. The laboratory is shipped ready to use with all devices, reagents, certificates, and protocols. After one day of preparation together with a local assistant, a five-day course is given where every step is carried out by each participant. Experts accompany the learning process with written teaching materials, video training, virtual live coaching, and short exams to verify the learned content.
As the COVID-19 pandemic continues, people are becoming infected at an alarming rate, individuals are unknowingly spreading disease, and more lives are lost every day. There is
an immediate need for a simple, rapid, early, and sensitive point-of-care testing for COVID-
19 disease. Recently,
clustered regularly interspaced short palindromic repeats (CRISPR)-based detection methods have received substantial attention for nucleic acid-based molecular testing due to their simplicity, high sensitivity and specificity. This review explores the various CRISPR-based COVID-19 detection methods and related diagnostic devices. As with any emerging technology, CRISPR/Cas-based nucleic acid testing methods have several
challenges that must be overcome for practical applications in clinics and hospitals. More importantly, these detection methods are not limited to COVID-19 but can be applied to detect any type of pathogen, virus, and fungi that may threaten humans, agriculture, and food industries in resource-limited settings. CRISPR/Cas-based detection methods have the potential to become simpler, more reliable, more affordable, and faster in the near future, which is highly important for achieving point-of-care diagnostics.
Dr. Richard Kerr - Development of an Effective Pathogen Screening Program usi...John Blue
Development of an Effective Pathogen Screening Program using Rapid, High-Throughput Molecular Detection Assays - Dr. Richard Kerr, Diagnostic R & D Lab Director, Daisy Farms, from the 2016 NIAA Annual Conference: From Farm to Table - Food System Biosecurity for Animal Agriculture, April 4-7, 2016, Kansas City, MO, USA.
More presentations at http://www.trufflemedia.com/agmedia/conference/2016_niaa_farm_table_food_system_biosecurity
Rapid Methodologies for Biosafety Testing of Biologic TherapeuticsMilliporeSigma
Learn about existing and emerging methods to accelerate biosafety testing of biologic therapies.
Speed to market for biologic therapeutics is ever more critical. However, the critical safety tests for these molecules, for example screening for adventitious agents such as viral contaminants, can be time consuming as well as challenging and laborious. Join us for this webinar as we explore how rapid methodologies are being used to not only accelerate this process, but also enhance quality by reducing testing complexity. Existing technologies as well as emerging trends will be discussed, along with the implications these may have on the regulatory landscape.
In this webinar you will learn:
● Which existing and emerging technologies are having now, and will have in the future, an impact on biosaftey testing.
● The benefits as well as risks of employing rapid methods for biosafety screening.
● How the regulatory agencies are reacting to rapid testing methods as alternatives to existing methods.
Rapid Methodologies for Biosafety Testing of Biologic TherapeuticsMerck Life Sciences
Learn about existing and emerging methods to accelerate biosafety testing of biologic therapies.
Speed to market for biologic therapeutics is ever more critical. However, the critical safety tests for these molecules, for example screening for adventitious agents such as viral contaminants, can be time consuming as well as challenging and laborious. Join us for this webinar as we explore how rapid methodologies are being used to not only accelerate this process, but also enhance quality by reducing testing complexity. Existing technologies as well as emerging trends will be discussed, along with the implications these may have on the regulatory landscape.
In this webinar you will learn:
● Which existing and emerging technologies are having now, and will have in the future, an impact on biosaftey testing.
● The benefits as well as risks of employing rapid methods for biosafety screening.
● How the regulatory agencies are reacting to rapid testing methods as alternatives to existing methods.
Microbial S.L. is a biotechnological company devoted to the design and production of products for the rapid detection of pathogen microorganisms in environmental and food samples.
Setting up for successful lot release testing by Edmund AngMilliporeSigma
Is your lot release testing strategy ready for global commercialization?
In this webinar, you will learn:
• CMC testing requirements with CHO production platform for global commercialization
• Lot release testing of product intermediates and final product
• Product-specific qualification study
• Alternative rapid testing methods to advance lot release testing
CHO cells continue to serve as a key cell substrate for the manufacturing of recombinant proteins that span beyond therapeutic monoclonal antibodies and including subunit vaccines.
In this presentation, we will cover the CMC testing requirements with CHO production platform for global commercialization, Lot release testing of product intermediates and final product, product-specific qualification study and highlight the application of new testing methods and the benefits they bring to advance Lot Release Testing.
Setting up for successful lot release testing by Edmund AngMerck Life Sciences
Is your lot release testing strategy ready for global commercialization?
In this webinar, you will learn:
• CMC testing requirements with CHO production platform for global commercialization
• Lot release testing of product intermediates and final product
• Product-specific qualification study
• Alternative rapid testing methods to advance lot release testing
CHO cells continue to serve as a key cell substrate for the manufacturing of recombinant proteins that span beyond therapeutic monoclonal antibodies and including subunit vaccines.
In this presentation, we will cover the CMC testing requirements with CHO production platform for global commercialization, Lot release testing of product intermediates and final product, product-specific qualification study and highlight the application of new testing methods and the benefits they bring to advance Lot Release Testing.
Public-Private Multistakeholder Platform for Last Mile Animal HealthcareEuFMD
To raise awareness on the new scope of practice of AHTs and the broader impact within the animal health sector.
To identify opportunities (both public and private sector mechanisms) to support AHTs in setting up sustainable businesses and improving smallholder farmer access to primary animal health care.
To develop a plan to support sustainable business development for AHTs.
To create an inclusive platform through which experiences and best models will be shared amongst members.
To facilitate collaboration among role players and act as an incubator for individual Public-Private Partnerships (PPP).
P. Compston - Identifying and addressing the barriers to effective FMD vaccin...EuFMD
Session VI
Foot-and-mouth disease (FMD) is endemic in Kenya, with frequent outbreaks. Understanding socioeconomic drivers affecting disease control within Kenya’s livestock systems, and the cost-effectiveness of control options, are important components of designing an FMD control programme. This study aimed to integrate quantitative economic analysis with qualitative data to provide recommendations for disease control.
R. McManus - Investigating gaps for novel animal health surveillance data wit...EuFMD
Session VI
Sensors have become ubiquitous in our current world and the livestock farming sector offers multiple research avenues for the application of sensor technology, from early disease detection to virtual fencing. Animal health surveillance in Scotland currently relies on post-mortem examinations of animals and on data derived from laboratory submitted samples. Sensor-derived syndromic surveillance of livestock has been identified as a gap in Scotland’s current animal health surveillance capabilities. Real-time data from on-farm herds has the potential to underpin improved production and endemic disease detection and the earlier identification and investigation of potential outbreaks. Using the data journeys approach, the aim of this project is to elucidate the conceptual journey of thermal imagery and drone-derived data from farm to policy. This approach aims to situate data across interconnected sites of practice, highlighting the movement of data in and between sites and exposing areas of potential ‘data friction’. The term ‘data friction’ is used to describe the complex factors (political, ethical, legal, social and economic) that come together to slow down and restrict data generation, movement and use.
S. Mielke - Is FMDV serotype C extinct: What can the data tell us?EuFMD
Session VI
Seven serotypes of foot-and-mouth disease virus (FMDV) (O, A, C, SAT (1, 2, 3), and Asia 1) occur across seven regional virus pools. In each pool, the specific serotypes that circulate in the susceptible populations varies. Since 2004 there has been a noticeable absence of serotype C from recorded outbreak data. This serotype historically occurred across European countries, however the most recent cases (2004) occurred in pool 4 (Eastern Africa) and pool 7 (South America). Detailed reports from these outbreaks suggest the outbreak in pool 4 resulted from vaccine escape, while in pool 7 the outbreak resulted from natural infection in an isolated cattle population. Following these outbreaks, response measures were taken to address the vaccine quality and coverage in isolated populations. Now, with continued lack of serotype C detection, we are evaluating whether the available data and knowledge about FMD epidemiology can substantiate a claim of serotype C extinction.
S. Gubbins - Longitudinal animal and environmental sampling for FMDV in North...EuFMD
Session VI
Environmental sampling, in particular taking swabs of any surfaces likely to have been contaminated by infected animals, presents an opportunity for non-invasive sample collection, enabling cost-effective FMD surveillance beyond regular investigation of clinical cases. Linking the results of environmental sampling with those of other surveillance methods (e.g. oral swabs or serum samples) allows a comparison of the methods and shows how the results of different sampling methods are correlated.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
LSD symposium - C. Batten - LSDV diagnostic capabilities at Pirbright
1. LSDV diagnostic capabilities at Pirbright
Dr Carrie Batten, Dr Caroline Wright and Dr Martin Ashby
The Pirbright Institute, United Kingdom
2. Lumpy Skin Disease Symposium; FAO-HQ, Rome; 14-16 March 2023
The Non-Vesicular Reference laboratories at Pirbright
3. Lumpy Skin Disease Symposium; FAO-HQ, Rome; 14-16 March 2023
• 8 WOAH reference laboratories
• Applications to FAO
• Diagnosis/confirmatory testing – 50 samples/year/country/disease
• Technical advice/diagnostic support: ISO/IEC 17025 accreditation
• Validated test protocols
• Lab contingency plan
• Participation (and supply) of PT panels
• Reagent supply
• Research collaborations leading to high impact scientific publications
The Non-Vesicular Reference laboratories at Pirbright
4. Lumpy Skin Disease Symposium; FAO-HQ, Rome; 14-16 March 2023
Primary diagnostic Real-time PCR: Capripox genus
Bowden et al., 2008; Sp: 100%
Good diagnostic sensitivity
Positive at ~ 4dpi (peak viraemia 10-12dpi)
ISO/IEC 17025 Accredited diagnostic tests
ID VET double antigen ELISA: 15-29dpi or vacc
Sp >97.3%, Se:98.6%
5. Lumpy Skin Disease Symposium; FAO-HQ, Rome; 14-16 March 2023
Diagnostic testing regime in the UK setting
APHA Report Case for
Capripox
EDTA
Blood /
Tissue
Serum
Real Time PCR Bowden
et al., 2008
(sample in duplicate)
Real time
PCR result
hours)
Report
Suspicion may be ruled
out at this point if real
time PCR results are
negative
Official veterinarians suspect LSDV
and submit samples to Pirbright
Other parties informed: Chief
Veterinary Officer, competent authority
(Defra), UK policy teams
Prescribed tests are performed in
duplicate
Suggested 2mm
biopsy of lump
6. Lumpy Skin Disease Symposium; FAO-HQ, Rome; 14-16 March 2023
▪ Magnetic silica based extraction MagMax CORE reagents
▪ Performs extraction of 96 sample in <40 mins
▪ 6 KingFishers available for use
KingFisher extraction platform
Rapid front line testing
▪ Capable of fast cycling conditions using fast reagents
▪ Applied Biosystems Path-ID qPCR master mix
▪ 6x QuantStudio 5 Real-Time PCR machines available for use
QuantStudio fast real-time PCR instruments
▪ Analysis duration for diagnostic sample ≤ 2 hours
▪ 12 scientists available for PCR and ELISA testing
▪ 24 hour on-call rota
7. Lumpy Skin Disease Symposium; FAO-HQ, Rome; 14-16 March 2023
Serum neutralisation test (6WP)
Confirmatory serological tests
PRNT – Plaque reduction neutralisation test
Foci (plaque)
formation
Move towards using a GFP expressing strain
8. Lumpy Skin Disease Symposium; FAO-HQ, Rome; 14-16 March 2023
Hong Kong
International disease confirmation
Sample
received
• Samples received 20th November 2020
Real-time
PCR
• Capripox virus confirmed using Bowden et al. assay
Real-time
PCR
• LSDV confirmed using FMCA Lamien et al. assay
Real-time
PCR
• LSDV “vaccine like” strain confirmed using Sprygin et al. assay
Virus
isolation
• Virus isolation successful using MDBK cells
9. Lumpy Skin Disease Symposium; FAO-HQ, Rome; 14-16 March 2023
Distinct areas of CPE leading to clear damage to the cell layer
Progress of infection for attenuated Neethling strain up to 9dpi (rapid)
MDBKs Infected with LSDV
Formation of ‘ridges’ during early stages of infection.
Slower progression
Nigeria 2021 (wild-type)
Control 4 dpi 5 dpi 9 dpi
x10
107 TCID50/ml
x4
10. Lumpy Skin Disease Symposium; FAO-HQ, Rome; 14-16 March 2023
Conventional
PCR
• PCR amplification of RPO30 & GPCR genes
Visualisation
• Amplicons confirmed on agarose gel
Purification
• Amplicons purified using GFX kit
Chain-
termination PCR
• Chain-termination PCR performed using the BigDye Terminator kit
Reading DNA
sequence
• Capillary gel electrophoresis and florescence detection using the ABI 3730 DNA analyzer
11. Lumpy Skin Disease Symposium; FAO-HQ, Rome; 14-16 March 2023
LSDV ‘Cluster’ a
mixture of wildtype
and vaccine strains
Complete RPO30
12. Lumpy Skin Disease Symposium; FAO-HQ, Rome; 14-16 March 2023
Recombinants – effect on diagnostic assays and
ability to differentiate LSDV vaccine v wildtype…
Differentiating Capripoxviruses
Suspected CaPV
sample
CaPV Real time PCR
(Bowden 2008)
Sheeppox Real-time PCR
(Wolff 2021)
Goatpox Real-time PCR
(Wolff 2021)
LSDV field Real-time PCR
(Wolff 2021)
LSDV vaccine-Real time
PCR (Wolff 2021)
If positive
Extract DNA
If negative
Report results
Report result
Report result
Report result
Report result
If positive
If negative
Possible
recombinant strain
If positive
If positive
If positive
alternative approach I
13. Lumpy Skin Disease Symposium; FAO-HQ, Rome; 14-16 March 2023
• Targeted sequencing of alternative capripoxvirus genes
• EEV
• Others
• Whole-genome sequencing…
alternative approach II
Differentiating Capripoxviruses
From virus isolation
Direct from clinical sample using
long-range pre-sequencing PCR
14. Lumpy Skin Disease Symposium; FAO-HQ, Rome; 14-16 March 2023
LSDV training course on behalf of FAO – 2022
LSDV training course at Pirbright 11th – 15th September 2023 – applications open now
https://www.pirbright.ac.uk/training-pirbright/instructor-led-training
LSDV e-learning
https://www.pirbright.ac.uk/training-pirbright/elearning-courses
Confirmatory diagnosis
Research collaborations
International engagement